What Happens When You Stop Weight Loss Injections?

A slower number on the scale doesn’t necessarily mean your GLP-1 treatment has stopped working.

The same is true in the other direction: stopping weight loss injections does not automatically mean you will regain every kilogram you lost.

However, research shows that some weight regain is common after GLP-1 treatment is discontinued. How much weight returns varies from person to person and depends on factors such as the medication used, duration of treatment, individual response, lifestyle, and what happens after treatment ends.

Clinical studies have now followed patients after stopping both semaglutide and tirzepatide. The results provide an important message for anyone considering stopping treatment: the end of an injection does not necessarily mean the end of weight-management care.

Planning for what happens next can be just as important as planning how to start treatment.

Will You Gain Weight Back After Stopping Weight Loss Injections?

The short answer is: you may regain some weight, but the amount varies.

One of the clearest examples comes from the STEP 1 trial extension. Participants who had received semaglutide for 68 weeks stopped both the medication and the structured lifestyle intervention and were followed for another year.

During the treatment period, participants receiving semaglutide lost an average of 17.3% of their body weight.

One year after treatment withdrawal, they had regained an average of 11.6 percentage points, leaving a net average loss of 5.6% from their original weight.

The researchers described this as regaining approximately two-thirds of the weight previously lost during treatment.

This does not mean every patient will regain two-thirds of their weight loss.

The study reported averages across a group of participants. Individual outcomes were different, and some participants maintained meaningful weight loss after stopping treatment.

What Did the Tirzepatide Study Show?

A similar pattern was observed in the SURMOUNT-4 trial, which looked specifically at what happened when people continued or discontinued tirzepatide.

Participants first received tirzepatide for 36 weeks and achieved an average weight reduction of 20.9% during that period.

They were then randomly assigned either to continue tirzepatide or switch to placebo for another 52 weeks.

The difference was substantial.

Those who continued tirzepatide lost another average 5.5% of their body weight during the following 52 weeks.

Those switched to placebo experienced an average 14.0% weight regain from the point of switching.

At week 88, 89.5% of people who continued tirzepatide maintained at least 80% of the weight they had lost during the initial treatment period, compared with 16.6% of those switched to placebo.

The study does not prove that every person needs to remain on tirzepatide indefinitely. Instead, it demonstrates that continuing treatment and withdrawing treatment produced different average weight trajectories in this study population.

Why Can Weight Return After Stopping GLP-1 Treatment?

GLP-1-based treatments can influence appetite, fullness, food intake, and metabolic regulation while a person is taking them.

When treatment stops, the medication is no longer providing the same pharmacological effect.

For some people, this may mean changes in:

• Appetite
• Fullness after meals
• Food intake
• Cravings
• Eating patterns

This does not necessarily happen immediately, and it does not happen in exactly the same way for everyone.

The important point is that weight regulation is biologically complex. Obesity is considered a chronic disease, and maintaining weight loss can require ongoing strategies even after the initial weight-loss phase. NIDDK notes that people may regain some weight after stopping weight-management medication and that healthy eating and physical activity can help with maintaining weight loss.

Does Everyone Regain All the Weight?

No.

This is one of the most important points to understand.

Clinical studies show average weight regain, not a guaranteed outcome for an individual.

The 2026 systematic review and nonlinear meta-regression included 48 studies examining weight outcomes after GLP-1 receptor agonist discontinuation.

Across six randomised controlled trials involving 3,236 participants, researchers found that approximately 60% of the weight lost during treatment was regained at one year after stopping.

Their modelling suggested that weight regain may eventually plateau at around 75% of the weight lost during treatment, although this longer-term estimate was extrapolated beyond the available follow-up data.

The researchers also found that the pattern of weight regain was broadly similar across studies involving liraglutide, semaglutide, and tirzepatide.

Importantly, the review noted that most included studies had a moderate risk of bias. The findings therefore help describe a general pattern but cannot predict exactly what will happen to one individual.

What Happens to Your Appetite After You Stop?

There is no single timeline for appetite changes after discontinuation.

While taking a GLP-1-based medication, some patients experience greater fullness and reduced appetite. After stopping, those effects may diminish.

Some people may notice:

• Hunger becoming more noticeable
• Larger portions becoming easier to eat
• More frequent food thoughts
• Cravings returning
• Less fullness between meals

However, it is too simplistic to say that everyone’s appetite will immediately return to exactly where it was before treatment.

Your eating habits, environment, physical activity, sleep, stress, and weight-management strategies can all influence what happens next.

This is why the transition period should be planned rather than treated as simply the end of treatment.

What Happens to Blood Sugar and Other Health Improvements?

The effects of stopping treatment may extend beyond body weight.

In the STEP 1 extension, several cardiometabolic improvements seen during semaglutide treatment moved back toward baseline after treatment was withdrawn.

The 2025 systematic review and meta-analysis of metabolic changes after GLP-1 receptor agonist discontinuation also examined changes in areas including:

• Blood glucose
• HbA1c
• Blood pressure
• Lipids
• Other cardiometabolic measures

The review was specifically designed to examine whether metabolic and cardiovascular improvements changed after GLP-1 treatment ended.

This is important because weight management medication may be part of a broader strategy for metabolic health.

If a patient has been using treatment partly because of blood sugar, blood pressure, or other health concerns, those factors should also be considered when planning discontinuation.

Do You Need to Stay on Weight Loss Medication Forever?

There is no universal answer.

Some people may use weight-management medication for a defined period, while others may require longer-term treatment.

According to NIDDK, how long someone needs weight-management medication depends on whether the medication is helping them lose weight and maintain that loss, as well as whether they experience serious side effects.

Factors that may influence the decision include:

• Treatment response
• Weight-management goals
• Side effects
• Medical history
• Existing health conditions
• Other medications
• Weight regain risk
• Lifestyle changes
• Long-term treatment plan

The important distinction is between “Do I need this medication forever?” and “What is the appropriate long-term plan for my health?”

The second question is much more useful.

How Can You Maintain Weight Loss After Stopping?

There is no strategy that guarantees you will maintain every kilogram of weight loss after stopping medication.

However, building sustainable habits can support long-term weight management.

Sustainable Eating

Rather than relying on extreme calorie restriction, focus on eating patterns that you can realistically maintain.

This may include balanced meals, appropriate portions, adequate protein, vegetables, fibre, and sufficient hydration.

Physical Activity

Regular physical activity supports overall health and can contribute to maintaining weight.

Strength Training

Resistance exercise can help maintain muscle mass and physical function during and after weight loss.

Sleep

Poor sleep can affect appetite, food choices, energy, and overall metabolic health.

Regular Monitoring

Keeping track of weight, waist circumference, blood pressure, or relevant blood tests may help identify changes early.

Ongoing Professional Support

Some patients may benefit from continued medical or nutritional support even after medication has stopped.

The aim is not perfection. It is to have a plan for maintaining progress.

Should You Stop Weight Loss Injections Suddenly?

Stopping or changing prescription medication should be discussed with the healthcare professional managing your treatment.

There is no universal stopping method that applies to every weight-loss injection.

The appropriate approach depends on:

• Which medication you are taking
• Why you are taking it
• Your current health
• Your treatment response
• Side effects
• Other medications
• Your long-term weight-management plan

Do not independently change the dose, extend the time between injections, or use a different dosing schedule based on advice found online.

A doctor can help determine whether stopping, continuing, or changing treatment is appropriate.

What If You Start Regaining Weight?

Weight regain does not necessarily mean that treatment has failed.

It may be a signal that your long-term weight-management strategy needs to be reviewed.

A doctor may look at:

• Recent weight changes
• Appetite
• Eating patterns
• Physical activity
• Sleep
• Medication adherence
• Current medical conditions
• Blood sugar
• Blood pressure
• Other medications

The earlier a change is identified, the more options there may be for adjusting the overall plan.

What About the “Metabolism Rebound”?

You may see claims online that stopping GLP-1 medication “destroys your metabolism” or causes a permanent metabolic problem.

The evidence does not support describing discontinuation in those terms.

Research shows that weight regain and changes in some metabolic markers can occur after treatment withdrawal.

But this is different from saying that the medication permanently damages metabolism.

Weight regulation involves many interacting biological and behavioural factors, and researchers are still studying the best strategies for maintaining weight after pharmacological treatment ends.

What a Doctor May Assess Before Stopping Treatment

A doctor-led approach may include:

• Medical consultation
• Weight and BMI review
• Weight trajectory
• Appetite and eating patterns
• Blood pressure
• Blood glucose
• HbA1c
• Cholesterol
• Current medications
• Treatment response
• Side effects
• Lifestyle factors
• Long-term weight-management plan

The purpose is to make sure the decision is based on your current health rather than simply reaching a particular number on the scale.

Benefits and Key Points to Understand

The evidence around stopping weight-loss injections gives us several important lessons.

• Weight regain after GLP-1 treatment is common, but not universal.
• Clinical studies report averages, not individual predictions.
• Some patients retain part of their weight loss after stopping.
• Appetite may change after treatment ends, but the timing and degree vary.
• Some cardiometabolic improvements may move back toward baseline.
• Continuing treatment and stopping treatment can produce different weight trajectories.
• Long-term weight management requires planning beyond the medication itself.
• Stopping or changing treatment should be discussed with a healthcare professional.

Most importantly, weight regain is not a personal failure. It can reflect the underlying chronic nature of weight regulation and the loss of a medication’s physiological effects.

Safety, Side Effects, and Important Considerations

GLP-1-based medications can cause side effects, particularly gastrointestinal symptoms.

Depending on the medication, these may include:

• Nausea
• Vomiting
• Diarrhoea
• Constipation
• Abdominal discomfort
• Reduced appetite

The SURMOUNT-4 trial reported that gastrointestinal adverse events were more common during tirzepatide treatment than during the placebo period after switching. Most reported events were mild to moderate.

Stopping treatment also requires consideration of the medical condition for which the medication was prescribed.

For example, patients using medication as part of diabetes management should not discontinue treatment without discussing an alternative plan with their healthcare professional.

Why Doctor-Led Care Matters

Stopping weight-loss medication is not simply a matter of taking the final injection.

A doctor can help you consider what happens next:

Continue treatment → modify treatment → transition treatment → stop treatment

The appropriate path depends on the individual.

Medical follow-up can also help identify weight regain early, review metabolic health, and address changes in appetite or other symptoms.

NIDDK recommends discussing weight-management medication decisions with a healthcare professional and notes that medication choice should consider potential benefits, side effects, health conditions, other medications, family history, and cost.

Weight Management After Treatment in Bangkok

If you are considering stopping a weight-loss injection, you do not have to make the decision based solely on what you read online.

At MedConsult Clinic in Bangkok, a doctor can review your treatment history, current weight, health markers, side effects, and long-term goals.

The focus can be on what happens after treatment as well as what happened during it.

weight management treatment in Bangkok

tirzepatide side effects

weight loss medication in Thailand

Mounjaro in Thailand

medical weight-management consultation